Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Cited by (1,054)

Items 301–400 of 1,054

1. Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-α both in vitro and in vivo systems
   Evros K. Vassiliou, Andrés González Gómez, Carlos Garcia, James H Tadros, Goutam Chakraborty, J. H. TONEY · 2009 · Lipids in Health and Disease
2. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
   Christina A. Reith, Colin Baigent, Lisa S. Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather J. Halls, Lisa Holland, Kate Wilson, Jane Armitage et al. · 2022 · The Lancet
3. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
   Barter, Philip J., Brandrup-Wognsen, Gunnar, Palmer, Mike K., Nicholls, Stephen J. · 2010 · Journal of Lipid Research
4. Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome
   Mario Leoncini, Anna Toso, Mauro Maioli, Francesco Tropeano, Simona Villani, Francesco Bellandi · 2013 · Journal of the American College of Cardiology
5. C-Reactive Protein Levels in Schizophrenia
   Brian J. Miller, Nick H. Culpepper, Mark Hyman Rapaport · 2013 · Clinical Schizophrenia & Related Psychoses
6. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease
   Vincent E. Friedewald, Kenneth S. Kornman, James D. Beck, Robert J. Genco, Allison B. Goldfine, Peter Libby, Steven Offenbacher, Paul M. Ridker, Thomas E. Van Dyke, William Clifford Roberts · 2009 · Journal of Periodontology
7. Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
   Davidson, Michael H., Ballantyne, Christie M., Jacobson, Terry A., Bittner, Vera A., Braun, Lynne T., Brown, Alan S., Brown, W.Virgil, Cromwell, William C., Goldberg, Ronald B., McKenney, James M. et al. · 2011 · Journal of Clinical Lipidology
8. The Coronary Artery Calcium Score and Stress Myocardial Perfusion Imaging Provide Independent and Complementary Prediction of Cardiac Risk
   Su Min Chang, Faisal Nabi, Jiaqiong Xu, Leif E. Peterson, Arup Achari, Craig M. Pratt, John J. Mahmarian · 2009 · Journal of the American College of Cardiology
9. Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
   Ridker, Paul M · 2019 · Circulation Research
10. One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease
    João Tomé‐Carneiro, Manuel Gonzálvez, Mar Larrosa, Maria Josefa Yáñez-Gascón, Francisco J. García‐Almagro, José A. Ruiz‐Ros, María‐Teresa García‐Conesa, Francisco Abraham Tomás-Barberán, Juan Carlos Espı́n · 2012 · The American Journal of Cardiology
11. The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature
    Evangelos Diamantis, Georgios Kyriakos, Lourdes Victoria Quiles-Sánchez, Paraskevi Farmaki, Theodoros G. Troupis · 2017 · Current Cardiology Reviews
12. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
    RICHARD J. KONES · 2011 · Drug Design Development and Therapy
13. Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy
    Pradhan, Aruna D., Aday, Aaron W., Rose, Lynda M., Ridker, Paul M · 2018 · Circulation
14. Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
    Senthong, Vichai, Li, Xinmin S., Hudec, Timothy, Coughlin, John, Wu, Yuping, Levison, Bruce, Wang, Zeneng, Hazen, Stanley L., Tang, W.H. Wilson · 2016 · Journal of the American College of Cardiology
15. Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease
    Arya, Shipra, Khakharia, Anjali, Binney, Zachary O., DeMartino, Randall R., Brewster, Luke P., Goodney, Philip P., Wilson, Peter W.F. · 2018 · Circulation
16. Cardiovascular Disease in COPD
    John D. Maclay, William MacNee · 2013 · CHEST Journal
17. Effects of statins on mitochondrial pathways
    Hamid Mollazadeh, Erfan Tavana, Giovanni Fanni, Simona Bo, Maciej Banach, Matteo Pirro, Stephan von Haehling, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2021 · Journal of Cachexia Sarcopenia and Muscle
18. Relation of C-Reactive Protein to Abdominal Adiposity
    Gabriel C. Brooks, Michael Joseph Blaha, Roger Scott Blumenthal · 2010 · The American Journal of Cardiology
19. Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
    Colhoun, Helen M., Betteridge, D. John, Durrington, Paul N., Hitman, Graham A., Neil, H. Andrew W., Livingstone, Shona J., Charlton-Menys, Valentine, DeMicco, David A., Fuller, John H. · 2009 · American Journal of Kidney Diseases
20. Triglycerides and residual atherosclerotic risk
    Raposeiras-Roubin, Sergio, Rosselló, Xavier, Oliva, Belén, Fernández-Friera, Leticia, Mendiguren, José M., Andrés, Vicente, Bueno, Héctor, Sanz, Javier, Martínez de Vega, Vicente, Abu-Assi, Emad et al. · 2021 · Journal of the American College of Cardiology
21. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
    Baxter, John D., Webb, Paul · 2009 · Nature Reviews Drug Discovery
22. A systematic review of statin-induced muscle problems in clinical trials
    Ganga, Harsha V., Slim, Hanna B., Thompson, Paul D. · 2014 · American Heart Journal
23. Coronary Artery Calcium Progression: An Important Clinical Measurement?
    John William McEvoy, Michael Joseph Blaha, Andrew Paul DeFilippis, Matthew Jay Budoff, Khurram Nasir, Roger Scott Blumenthal, Steven Richard Jones · 2010 · Journal of the American College of Cardiology
24. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial
    Glynn, Robert J., Koenig, Wolfgang, Nordestgaard, Børge G., Shepherd, James, Ridker, Paul M · 2010 · Annals of Internal Medicine
25. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
    Paul M. Ridker, Jacques J. Genest, S. Matthijs Boekholdt, Peter Libby, Antonio M. Gotto, Børge Grønne Nordestgaard, Samia Mora, Jean G. MacFadyen, Robert J. Glynn, John J.P. Kastelein · 2010 · The Lancet
26. HIV infection and cardiovascular disease
    Hemkens, L. G., Bucher, H. C. · 2014 · European Heart Journal
27. Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
    Ashish M. Kamat, Thomas W. Flaig, H. Barton Grossman, Badrinath R. Konety, Donald L. Lamm, Michael A. O’Donnell, Edward Uchio, Jason Alexander Efstathiou, John Arthur Taylor · 2015 · Nature Reviews Urology
28. Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular Disease
    Seth Shay Martin, Michael Joseph Blaha, Ron Blankstein, Arthur A. Agatston, Juan J. Rivera, Salim S. Virani, Pamela Ouyang, Steven Richard Jones, Roger Scott Blumenthal, Matthew Jay Budoff et al. · 2013 · Circulation
29. Justificación y métodos del estudio sobre nutrición y riesgo cardiovascular en España (ENRICA)
    Fernando Rodríguez‐Artalejo, Auxiliadora Graciani, Pilar Guallar‐Castillón, Luz María León-Muñoz, M. Clemencia Zuluaga, Esther López‐García, Juan Luis Gutiérrez-Fisac, José M. Taboada, María Teresa Aguilera, Enrique Regidor et al. · 2011 · Revista Española de Cardiología
30. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions
    Mark Daniel DeBoer · 2012 · Nutrition
31. Pathogenesis of Acute Coronary Syndromes
    Filippo Crea, Giovanna Liuzzo · 2012 · Journal of the American College of Cardiology
32. Meta-Analysis of Statin Effects in Women Versus Men
    William J. Kostis, Jerry Cheng, Jeanne M. Dobrzynski, Javier Cabrera, John B. Kostis · 2012 · Journal of the American College of Cardiology
33. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
    Colin R. Dormuth, Brenda R. Hemmelgarn, J. Michael Paterson, Matthew Thomas James, Gary F. Teare, Colette B. Raymond, Jean‐Philippe Lafrance, Adrian R. Levy, Amit X. Garg, Pierre Ernst et al. · 2013 · BMJ
34. High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
    Ian Ford, Anoop S.V. Shah, Ruiqi Zhang, David McAllister, Fiona E. Strachan, MURIEL J. CASLAKE, David Ernest Newby, Chris J. Packard, Nicholas L. Mills · 2016 · Journal of the American College of Cardiology
35. Systemic Manifestations of COPD
    Yvonne Nussbaumer‐Ochsner, Klaus Friedrich Rabe · 2011 · CHEST Journal
36. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
    Blumenthal, Roger S., Morris, Pamela B., Gaudino, Mario, Johnson, Heather M., Anderson, Timothy S., Bittner, Vera A., Blankstein, Ron, Brewer, LaPrincess C., Cho, Leslie, de Ferranti, Sarah D. et al. · 2026 · JACC
37. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus
    Giuseppe Daniele, Rodolfo Guardado‐Mendoza, Deidre A. Winnier, Teresa Vanessa Fiorentino, Pengou Zuo, John E. Cornell, Francesco Andreozzi, Christopher P. Jenkinson, Eugênio Cersósimo, Massimo Federici et al. · 2013 · Acta Diabetologica
38. Inflammation in Children and Adolescents With Neuropsychiatric Disorders: A Systematic Review
    Rachel H. B. Mitchell, Benjamin I. Goldstein · 2013 · Journal of the American Academy of Child & Adolescent Psychiatry
39. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
    Derek M. Klarin, Veterans Affairs’ Million Veteran Program, Emma Busenkell, Renae Judy, Julie Ann Lynch, Michael G. Levin, Jeff Haessler, Krishna G. Aragam, Mark D. Chaffin, Mary Haas et al. · 2019 · Nature Genetics
40. Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis
    Michael D. Miedema, Daniel A. Duprez, Jeffrey R. Misialek, Michael Joseph Blaha, Khurram Nasir, Michael G. Silverman, Ron Blankstein, Matthew Jay Budoff, Philip Greenland, Aaron R. Folsom · 2014 · Circulation Cardiovascular Quality and Outcomes
41. Coronary heart disease risk: Low-density lipoprotein and beyond
    Gabriel E. Shaya, Thorsten Martin Leucker, Steven Richard Jones, Seth Shay Martin, Peter Paul Toth · 2021 · Trends in Cardiovascular Medicine
42. Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Brian R. Ott, Lori A. Daiello, Issa J Dahabreh, Beth A. Springate, Kimberly Bixby, Manjari Murali, Thomas A Trikalinos · 2015 · Journal of General Internal Medicine
43. Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study
    Ford, Ian, Murray, Heather, McCowan, Colin, Packard, Chris J. · 2016 · Circulation
44. High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy
    Samia Mora, Robert J. Glynn, Paul M. Ridker · 2013 · Circulation
45. Multiple Markers of Inflammation and Weight Status: Cross-sectional Analyses Throughout Childhood
    Asheley Cockrell Skinner, Michael J. Steiner, Frederick W. Henderson, Eliana Miller Perrin · 2010 · PEDIATRICS
46. Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells
    Sabine Rütti, Jan A. Ehses, Rahel Sibler, Richard Prazak, Lucia Rohrer, Spiros Georgopoulos, Daniel T. Meier, Nadja Niclauß, Thierry Berney, Marc Yves Donath et al. · 2009 · Endocrinology
47. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity
    Partha S. Kar, David W Laight, HARCHARAN KAUR ROOPRAI, Kenneth M Shaw, M. H. Cummings · 2009 · Diabetic Medicine
48. Lupus Atherosclerosis Prevention Study (LAPS)
    Michelle A. Petri, Adnan N. Kiani, Wendy S. Post, Lisa Christopher‐Stine, Laurence S. Magder · 2010 · Annals of the Rheumatic Diseases
49. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
    Thimoteus Speer, Stefanie Dimmeler, Stefan J. Schunk, Danilo Fliser, Paul M. Ridker · 2022 · Nature Reviews Nephrology
50. Mechanisms for the anti-inflammatory effects of statins
    De-xiu Bu, Gabriel Kenneth Griffin, Andrew H. Lichtman · 2011 · Current Opinion in Lipidology
51. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function
    Heike Wersching, Thomas Duning, Hubertus Lohmann, Siawoosh Mohammadi, Christoph Stehling, Manfred Fobker, M. Conty, Jens Minnerup, E.B. Ringelstein, Klaus Berger et al. · 2010 · Neurology
52. C-reactive protein is a mediator of cardiovascular disease
    Radjesh J. Bisoendial, S. Matthijs Boekholdt, Menno Vergeer, Erik S.G. Stroes, John J.P. Kastelein · 2010 · European Heart Journal
53. 8. Cardiovascular Disease and Risk Management
    American Diabetes Association · 2014 · Diabetes Care
54. Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
    Hsia, Judith, MacFadyen, Jean G., Monyak, John, Ridker, Paul M. · 2011 · Journal of the American College of Cardiology
55. Inflammation and nutritional science for programs/policies and interpretation of research evidence (INSPIRE)
    Raiten, Daniel J, Ashour, Fayrouz A Sakr, Ross, A Catharine, Meydani, Simin N, Dawson, Harry D, Stephensen, Charles B, Brabin, Bernard J, Suchdev, Parminder S, van Ommen, Ben · 2015 · The Journal of Nutrition
56. High-sensitivity assays for troponin in patients with cardiac disease
    Westermann, Dirk, Neumann, Johannes Tobias, Sörensen, Nils Arne, Blankenberg, Stefan · 2017 · Nature Reviews Cardiology
57. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients
    Koh, Kwang Kon, Quon, Michael J., Han, Seung Hwan, Lee, Yonghee, Kim, Soo Jin, Shin, Eak Kyun · 2010 · Journal of the American College of Cardiology
58. The Relationship between Lung Inflammation and Cardiovascular Disease
    Stephan F. van Eeden, Jonathon A Leipsic, S. F. Paul Man, Don D. Sin · 2012 · American Journal of Respiratory and Critical Care Medicine
59. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
    Chapman, M. John, Redfern, Jan S., McGovern, Mark E., Giral, Philippe · 2010 · Pharmacology & Therapeutics
60. Acute Coronary Syndrome
    Benjamin M. Scirica · 2010 · Journal of the American College of Cardiology
61. Cytokine production by islets in health and diabetes: cellular origin, regulation and function
    Marc Yves Donath, Marianne Böni‐Schnetzler, Helga Ellingsgaard, Philippe A. Halban, Jan A. Ehses · 2010 · Trends in Endocrinology and Metabolism
62. Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology
    Brian E. Sansbury, Matthew R. Spite · 2016 · Circulation Research
63. 2023 Chinese guideline for lipid management
    Jian‐Jun Li, Shui‐Ping Zhao, Dong Hui Zhao, Guoping Lü, Daoquan Peng, Jing Liu, Zhen‐Yue Chen, Yuan‐Lin Guo, Na‐Qiong Wu, Sheng-kai Yan et al. · 2023 · Frontiers in Pharmacology
64. Evidence that periodontal treatment improves biomarkers and CVD outcomes
    Francesco D’Aiuto, Marco Orlandi, John C. Gunsolley · 2013 · Journal Of Clinical Periodontology
65. Lipid parameters for measuring risk of cardiovascular disease
    Benoît J. Arsenault, S. Matthijs Boekholdt, John J.P. Kastelein · 2011 · Nature Reviews Cardiology
66. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
    Ting Cai, Lucy Abel, Oliver Langford, G Monaghan, Jeffrey K Aronson, Richard Stevens, Sarah L Lay-Flurrie, Constantinos Koshiaris, Richard J. McManus, Richard F. Hobbs et al. · 2021 · BMJ
67. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
    Mangravite, Lara M., Engelhardt, Barbara E., Medina, Marisa W., Smith, Joshua D., Brown, Christopher D., Chasman, Daniel I., Mecham, Brigham H., Howie, Bryan, Shim, Heejung, Naidoo, Devesh et al. · 2013 · Nature
68. Biomarkers of immune dysfunction in HIV
    Daniel E. Nixon, ALAN L. LANDAY · 2010 · Current Opinion in HIV and AIDS
69. Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents
    Paul M. Ridker, Samia Mora, Lynda M. Rose · 2016 · European Heart Journal
70. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events
    Amit V. Khera, Olga Demler, Steven J. Adelman, Heidi L. Collins, Robert J. Glynn, Paul M. Ridker, Daniel James Rader, Samia Mora · 2017 · Circulation
71. Inflammation and Stroke Risk: A New Target for Prevention
    Peter J. Kelly, Robin Lemmens, Georgios K. Tsivgoulis · 2021 · Stroke
72. Phenotype standardization for statin-induced myotoxicity
    Alfirevic, A, Neely, D, Armitage, J, Chinoy, H, Cooper, R G, Laaksonen, R, Carr, D F, Bloch, K M, Fahy, J, Hanson, A et al. · 2014 · Clinical Pharmacology & Therapeutics
73. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk
    Shapiro, Michael D., Fazio, Sergio · 2016 · Circulation Research
74. Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein
    Paul M. Ridker, Jean G. MacFadyen, Michael D. Cressman, Robert J. Glynn · 2010 · Journal of the American College of Cardiology
75. Progressive Staging of Pilot Studies to Improve Phase III Trials for Motor Interventions
    Bruce H. Dobkin · 2008 · Neurorehabilitation and neural repair
76. Short-Term Rosuvastatin Therapy for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
    Yaling Han, Guoying Zhu, Han Lixian, Fengxia Hou, Weijian Huang, Huiliang Liu, Jihong Gan, Tiemin Jiang, Xiaoyan Li, Wei Wang et al. · 2013 · Journal of the American College of Cardiology
77. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors
    US Preventive Services Task Force, Susan J. Curry, Alex H. Krist, Douglas K Owens, Michael J. Barry, Aaron Brandon Caughey, Karina W. Davidson, Chyke A. Doubeni, John W. Epling, Alex R. Kemper et al. · 2018 · JAMA
78. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
    Lin, Jennifer S., Evans, Corinne V., Johnson, Eric, Redmond, Nadia, Coppola, Erin L., Smith, Ning · 2018 · JAMA
79. Statin treatment and new-onset diabetes: A review of proposed mechanisms
    Marilyne Brault, Jessica Ray, Yessica-Haydee Gomez Sandoval, Christos Socrates Mantzoros, Stella Styliani Daskalopoulou · 2014 · Metabolism
80. The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials
    Catherine Mary Schooling, Shiu Lun Au Yeung, Guy Freeman, Benjamin John Cowling · 2013 · BMC Medicine
81. NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases
    Antonella Fiordelisi, Guido Iaccarino, Carmine Morisco, Enrico Coscioni, Daniela Sorriento · 2019 · International Journal of Molecular Sciences
82. Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
    David T. Paik, Mark Chandy, Joseph C. Wu · 2019 · Pharmacological Reviews
83. Association of Metabolic Syndrome and Hidradenitis Suppurativa
    Iben Marie Miller, Christina Ellervik, Gabrielle Randskov Vinding, Kian Zarchi, Kristina Sophie Ibler, Kim Mark Knudsen, Gregor B. E. Jemec · 2014 · JAMA Dermatology
84. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
    Anne Grete Semb, Eirik Ikdahl, Grunde Wibetoe, Cynthia S. Crowson, Silvia Rollefstad · 2020 · Nature Reviews Rheumatology
85. Cardiovascular disease in diabetes, beyond glucose
    Robert H. Eckel, Karin Bornfeldt, Ira J. Goldberg · 2021 · Cell Metabolism
86. Evaluating Health Outcomes in the Presence of Competing Risks
    Ravi Varadhan, Carlos O. Weiss, Jodi B Segal, Albert W. Wu, Daniel O. Scharfstein, Cynthia M. Boyd · 2010 · Medical Care
87. Chronic Inflammatory Diseases and Cardiovascular Risk: A Systematic Review
    Idan Roifman, Paul L. Beck, Todd J. Anderson, Mark Jeffrey Eisenberg, Jacques J. Genest · 2011 · Canadian Journal of Cardiology
88. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
    Sarah J. Zaman, Jason H. Wasfy, Vikas Kapil, Boback Ziaeian, William Anthony Parsonage, Sira Sriswasdi, Tim Chico, Davide Capodanno, Róisín Colleran, Nadia R. Sutton et al. · 2025 · The Lancet
89. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study
    Lorenz Räber, Masanori Taniwaki, Serge Zaugg, Henning Kelbæk, Marco Roffi, Lene Holmvang, Stéphane Noble, Giovanni Pedrazzini, Aris Moschovitis, Thomas Felix Lüscher et al. · 2014 · European Heart Journal
90. 2018 Guidelines for the management of dyslipidemia
    Eun‐Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Byung Jin Kim, Seonghoon Choi et al. · 2019 · The Korean Journal of Internal Medicine
91. Chemistry and Biology in the Biosynthesis and Action of Thyroid Hormones
    Santanu Mondal, Karuppusamy Raja, Ulrich Schweizer, Govindasamy Mugesh · 2016 · Angewandte Chemie International Edition
92. Effect of Rosuvastatin on Coronary Atheroma in Stable Coronary Artery Disease Multicenter Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects (COSMOS)
    Tadateru Takayama, Takafumi Hiro, Masakazu Yamagishi, Hiroyuki Daida, Atsushi Hirayama, Satoshi Saito, Tetsu Yamaguchi, Masunori Matsuzaki, The COSMOS Investigators · 2009 · Circulation Journal
93. Impact of Statin Therapy on Plaque Characteristics as Assessed by Serial OCT, Grayscale and Integrated Backscatter–IVUS
    Kousuke Hattori, Yukio Ozaki, Tevfik Fehmi Ismail, Masanori Okumura, Hiroyuki Naruse, Shino C. Kan, Makoto Ishikawa, Tomoko Kawai, Masaya Ohta, Hideki Kawai et al. · 2012 · JACC. Cardiovascular imaging
94. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease††Published simultaneously in the Journal of Periodontology, the Official Journal of the American Academy of Periodontology.
    Vincent E. Friedewald, Kenneth S. Kornman, James D. Beck, Robert J. Genco, Allison B. Goldfine, Peter Libby, Steven Offenbacher, Paul M. Ridker, Thomas E. Van Dyke, William Clifford Roberts · 2009 · The American Journal of Cardiology
95. How do we improve patient compliance and adherence to long-term statin therapy?
    Maningat, Patricia, Gordon, Bruce R., Breslow, Jan L. · 2013 · Current Atherosclerosis Reports
96. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease
    Ridker, Paul M · 2009 · Clinical Chemistry
97. C-reactive protein and Hypertension
    Hage, F G · 2014 · Journal of Human Hypertension
98. Brain inflammation is induced by co-morbidities and risk factors for stroke
    Caroline Drake, Hervé Boutin, Matthew S. Jones, Ádám Dénes, Barry W. McColl, Johann R. Selvarajah, Sharon Hulme, Rachel F. Georgiou, Rainer Hinz, Alexander Gerhard et al. · 2011 · Brain Behavior and Immunity
99. Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
    Kühnast, Susan, van der Hoorn, José W.A., Pieterman, Elsbet J., van den Hoek, Anita M., Sasiela, William J., Gusarova, Viktoria, Peyman, Anusch, Schäfer, Hans-Ludwig, Schwahn, Uwe, Jukema, J. Wouter et al. · 2014 · Journal of Lipid Research
100. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study
     Bhanpuri, Nasir H., Hallberg, Sarah J., Williams, Paul T., McKenzie, Amy L., Ballard, Kevin D., Campbell, Wayne W., McCarter, James P., Phinney, Stephen D., Volek, Jeff S. · 2018 · Cardiovascular Diabetology